Cover Image

Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

Objective: Hypertension is the most prevalent modifiable risk factor for cardiovascular (CV) and cerebrovascular morbidity and mortality. This study aimed to assess the effects of renin-angiotensin-aldosterone system (RAAS) blockade on CV outcomes. Methods: This study was designed according to the P...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pınar Kızılırmak (Author), Yağız Üresin (Author), Oktay Özdemir (Author), Burçak Kılıçkıran Avcı (Author), Lale Tokgözoğlu (Author), Zeki Öngen (Author)
Format:	Book
Published:	KARE Publishing, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Renin-Angiotensin Aldosterone System
Published: (2021)

New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Overview of Regulation of the Renin-Angiotensin-Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010)

Systematic Review and Meta-Analysis of Renin-Angiotensin-Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
by: Katsunori Yanai, et al.
Published: (2021)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
by: Nancy Houston Miller
Published: (2010)

New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Mineralocorticoid-Receptor Blockers Exert Antihypertensive and Renoprotective Effects Independently of the Renin-Angiotensin System
by: Akira Nishiyama, et al.
Published: (2010)

Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
by: Nestor Vazquez-Agra, et al.
Published: (2023)

Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review
by: Pınar Kızılırmak, et al.
Published: (2020)

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
by: Ewa Szczepanska-Sadowska, et al.
Published: (2021)

The renin angiotensin aldosterone system and COVID-19
by: Hadeel A. Alsufyani, et al.
Published: (2020)

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
by: Kiuchi S, et al.
Published: (2015)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2014)

Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2015)

Unilateral absence of the left pulmonary artery with patent ductus arteriosus and interrupted inferior vena cava
by: Burçak Kılıçkıran Avcı, et al.
Published: (2014)

Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions
by: Paolo Cimaglia MD, et al.
Published: (2022)

Renin-angiotensin-aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis
by: Upinder Kaur, et al.
Published: (2021)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin-Angiotensin-Aldosterone System Blockers
by: Yuichiro Ueda, et al.
Published: (2016)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin-Angiotensin-Aldosterone System Blockers
by: Yuichiro Ueda, et al.
Published: (2016)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
by: Si-Hyuck Kang, et al.
Published: (2021)

New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
by: Atsuhiro Ichihara, et al.
Published: (2010)

Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
by: Selçuk Görmez, et al.
Published: (2021)

New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Evidence From Randomized Controlled Trials (RCTs) of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II-Receptor Blockers - Questions Remain Unsolved
by: Shinichiro Ueda
Published: (2010)

ELECTRICAL FIELD STIMULATION OF THE RENIN ANGIOTENSIN ALDOSTERONE SYSTEM ON UTERINE SMOOTH MUSCLE
by: Stafie Liviu, et al.
Published: (2024)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021)

Stroke, high blood pressure and the renin-angiotensin-aldosterone system - new developments
by: Jeffrey eAtkinson
Published: (2011)

Evaluation of Renin, Aldosterone, Angiotensin, and Lipid Metabolism Genes and Genotype-Phenotype Relationship in Childhood Primary Hypertension Pathogenesis
by: Özgür Özdemir Şimşek, et al.
Published: (2022)

The use of renin-angiotensin system blockers in patients with COVID-19
by: Anton V. Rodionov
Published: (2021)

Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
by: Monika Cahova, et al.
Published: (2021)

Role of renin-angiotensin-aldosterone system inhibitors in heart failure and chronic kidney disease
by: Namrata Singhania, et al.
Published: (2020)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015)

Renin-angiotensin-aldosterone pathway modulators in chronic kidney disease: A comparative review
by: Saeed Alshahrani
Published: (2023)

The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
by: Eugenie R. Lumbers, et al.
Published: (2022)

The activity of the renin-angiotensin-aldosterone system before and after parathyroidectomy in patients with primary hyperparathyroidism
by: Liubov G. Yanevskaya, et al.
Published: (2021)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015)

The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID‐19
by: Cássia L. Braga, et al.
Published: (2020)

Disorders of water-electrolyte metabolism in pulmonary edema under inhibition of the renin-angiotensin-aldosterone system
by: T. I. Tiupka, et al.
Published: (2018)

Renin-Angiotensin-Aldosterone System in Women Using Combined Oral Contraceptive: A Systematic Review
by: Priscilla Araújo dos Santos, et al.
Published: (2022)

Disorders of water-electrolyte metabolism in pulmonary edema under inhibition of the renin-angiotensin-aldosterone system
by: T. I. Tiupka, et al.
Published: (2018)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
by: M. Ekholm, et al.
Published: (2021)